Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Revenue (2019 - 2025)

Historic Revenue for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $272.3 million.

  • Legend Biotech's Revenue rose 6998.85% to $272.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $187.2 billion, marking a year-over-year increase of 13433.46%. This contributed to the annual value of $627.2 million for FY2024, which is 11997.42% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Revenue is $272.3 million, which was up 6998.85% from $255.1 million recorded in Q2 2025.
  • Legend Biotech's 5-year Revenue high stood at $186.5 billion for Q4 2024, and its period low was $12.0 million during Q2 2022.
  • Moreover, its 5-year median value for Revenue was $73.3 million (2023), whereas its average is $14.1 billion.
  • As far as peak fluctuations go, Legend Biotech's Revenue plummeted by 4083.43% in 2022, and later soared by 28746921.07% in 2023.
  • Over the past 5 years, Legend Biotech's Revenue (Quarter) stood at $39.0 million in 2021, then decreased by 29.14% to $27.6 million in 2022, then skyrocketed by 287469.21% to $79.5 billion in 2023, then surged by 134.73% to $186.5 billion in 2024, then tumbled by 99.85% to $272.3 million in 2025.
  • Its last three reported values are $272.3 million in Q3 2025, $255.1 million for Q2 2025, and $195.1 million during Q1 2025.